OneSource Speci.

{
  "main_header": {
    "sid": 10039523,
    "name": "OneSource Speci.",
    "stock_name": "OneSource Speci.",
    "full_name": "OneSource Specialty Pharma Ltd",
    "name_url": "stocks-analysis/onesource-speci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,867.60",
    "chg": 14,
    "chgp": "0.76%",
    "dir": 1,
    "prev_price": "1,853.60",
    "mcapval": "21,477.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544292,
    "symbol": "ONESOURCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE013P01021",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "2.78 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onesource-speci-10039523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "OneSource Specialty Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3998197",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OneSourceSpecia_technicaldot_3998197.png",
        "date": "2026-05-19 08:07:52",
        "description": "OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators present a complex picture, with bullish signals on some fronts and bearish or neutral cues on others, reflecting a period of consolidation and cautious investor sentiment."
      },
      {
        "title": "OneSource Specialty Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/onesource-specialty-pharma-ltd-is-rated-sell-3995292",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OneSourceSpecia_mojoScore_3995292.png",
        "date": "2026-05-17 10:10:27",
        "description": "OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "OneSource Specialty Pharma’s Mixed Week: -0.09% Price Change Amid Margin Pressures and Technical Uncertainty",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharmas-mixed-week--009-price-change-amid-margin-pressures-and-technical-uncertainty-3993740",
        "imagepath": "",
        "date": "2026-05-16 09:06:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>11 May:</strong> Stock opens at Rs.1,835.95, declines 1.85% amid broader market sell-off</p>\n                    <p><strong>12 May:</strong> Mixed technical signals emerge; stock rebounds 1.76% to Rs.1,833.55</p>\n                    <p><strong>13 May:</strong> Q4 FY26 results reveal margin collapse despite revenue growth; stock falls 2.34%</p>\n                    <p><strong>14 May:</strong> Flat quarterly performance reported amid margin pressures; stock recovers 1.66%</p>\n                    <p><strong>15 May:</strong> Week closes at Rs.1,834.35, down 0.09% for the week, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <..."
      },
      {
        "title": "Are OneSource Specialty Pharma Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-onesource-specialty-pharma-ltd-latest-results-good-or-bad-3991764",
        "imagepath": "",
        "date": "2026-05-14 19:23:13",
        "description": "OneSource Specialty Pharma Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by significant revenue growth but substantial profitability challenges. The company reported net sales of ₹428.22 crores, reflecting a robust sequential increase of 47.49% from the previous quarter. This marks the highest quarterly sales figure on record, indicating a potential recovery in demand or successful product launches.\n\nHowever, despite this top-line growth, the net profit stood at ₹4.60 crores, which represents a dramatic decline of 95.33% year-on-year. This stark contrast highlights the company's struggle to convert revenue into profit, as evidenced by the operating margin, which fell to 21.47%, down 21.38 percentage points from the same quarter last year. Such margin compression suggests underlying issues, possibly related to pricing pressures, unfavorable product mix, or ri..."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-reports-flat-quarterly-performance-amid-margin-pressures-3990294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OneSourceSpecia_fintrenddot_3990294.png",
        "date": "2026-05-14 08:00:17",
        "description": "OneSource Specialty Pharma Ltd has reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from previous negative trends. Despite achieving its highest quarterly net sales to date, the company faced significant pressure on profitability, with a sharp decline in net profit after tax (PAT) signalling ongoing challenges in margin management."
      },
      {
        "title": "OneSource Specialty Pharma Q4 FY26: Margin Collapse Masks Revenue Recovery",
        "link": "https://www.marketsmojo.com/news/result-analysis/onesource-specialty-pharma-q4-fy26-margin-collapse-masks-revenue-recovery-3990046",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OneSourceSpecia_quaterlyResult_3990046.png",
        "date": "2026-05-13 19:34:15",
        "description": "OneSource Specialty Pharma Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹20,747 crores, reported a dramatic 95.33% year-on-year decline in consolidated net profit to ₹4.60 crores for Q4 FY26, despite achieving modest revenue growth. The stock has declined 2.34% following the results announcement, reflecting investor concerns over profitability erosion even as the company managed to recover from the previous quarter's substantial losses."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Faces Mixed Technical Signals Amid Mildly Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-faces-mixed-technical-signals-amid-mildly-bearish-momentum-3986741",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OneSourceSpecia_technicaldot_3986741.png",
        "date": "2026-05-12 08:09:34",
        "description": "OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, the stock’s daily moving averages and relative strength index (RSI) suggest caution for investors as price momentum shows signs of weakening."
      },
      {
        "title": "When is the next results date for OneSource Specialty Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-onesource-specialty-pharma-ltd-3982503",
        "imagepath": "",
        "date": "2026-05-08 23:17:32",
        "description": "The next results date for OneSource Specialty Pharma Ltd is scheduled for 13 May 2026...."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3980883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OneSourceSpecia_technicaldot_3980883.png",
        "date": "2026-05-08 08:05:57",
        "description": "OneSource Specialty Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a strong day change of 4.24%, the stock’s technical indicators present a complex picture, with bullish signals on weekly MACD and Bollinger Bands contrasting with bearish RSI and mildly bearish daily moving averages. This nuanced technical landscape warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 216,
    "sid": "10039523",
    "stock_news_url": "https://www.marketsmojo.com/news/onesource-specialty-pharma-10039523"
  },
  "announcements": [
    {
      "caption": "General- Update",
      "datetime": "19-May-2026",
      "details": "In furtherance to the intimation dated May 13 2026 w.r.t the resignation of SMP please find enclosed the resignation document.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "19-May-2026",
      "details": "Intimation of Transcript of Earnings call dated May 13 2026",
      "source": "BSE"
    },
    {
      "caption": "General-Update",
      "datetime": "16-May-2026",
      "details": "We wish to inform that the Government of Karnataka has accorded in-principle approval for the application submitted by the Company for Unit-II expansion project under the Karnataka Industrial Policy (KIP) 2025-30 towards incentives and concessions.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

OneSource Specialty Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-19 08:07:52

OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators present a complex picture, with bullish signals on some fronts and bearish or neutral cues on others, reflecting a period of consolidation and cautious investor sentiment.

Read full news article

OneSource Specialty Pharma Ltd is Rated Sell

2026-05-17 10:10:27

OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

OneSource Specialty Pharma’s Mixed Week: -0.09% Price Change Amid Margin Pressures and Technical Uncertainty

2026-05-16 09:06:54

Key Events This Week

11 May: Stock opens at Rs.1,835.95, declines 1.85% amid broader market sell-off

12 May: Mixed technical signals emerge; stock rebounds 1.76% to Rs.1,833.55

13 May: Q4 FY26 results reveal margin collapse despite revenue growth; stock falls 2.34%

14 May: Flat quarterly performance reported amid margin pressures; stock recovers 1.66%

15 May: Week closes at Rs.1,834.35, down 0.09% for the week, outperforming Sensex

<...

Read full news article

Are OneSource Specialty Pharma Ltd latest results good or bad?

2026-05-14 19:23:13

OneSource Specialty Pharma Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by significant revenue growth but substantial profitability challenges. The company reported net sales of ₹428.22 crores, reflecting a robust sequential increase of 47.49% from the previous quarter. This marks the highest quarterly sales figure on record, indicating a potential recovery in demand or successful product launches. However, despite this top-line growth, the net profit stood at ₹4.60 crores, which represents a dramatic decline of 95.33% year-on-year. This stark contrast highlights the company's struggle to convert revenue into profit, as evidenced by the operating margin, which fell to 21.47%, down 21.38 percentage points from the same quarter last year. Such margin compression suggests underlying issues, possibly related to pricing pressures, unfavorable product mix, or ri...

Read full news article

OneSource Specialty Pharma Ltd Reports Flat Quarterly Performance Amid Margin Pressures

2026-05-14 08:00:17

OneSource Specialty Pharma Ltd has reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from previous negative trends. Despite achieving its highest quarterly net sales to date, the company faced significant pressure on profitability, with a sharp decline in net profit after tax (PAT) signalling ongoing challenges in margin management.

Read full news article

OneSource Specialty Pharma Q4 FY26: Margin Collapse Masks Revenue Recovery

2026-05-13 19:34:15

OneSource Specialty Pharma Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹20,747 crores, reported a dramatic 95.33% year-on-year decline in consolidated net profit to ₹4.60 crores for Q4 FY26, despite achieving modest revenue growth. The stock has declined 2.34% following the results announcement, reflecting investor concerns over profitability erosion even as the company managed to recover from the previous quarter's substantial losses.

Read full news article

OneSource Specialty Pharma Ltd Faces Mixed Technical Signals Amid Mildly Bearish Momentum

2026-05-12 08:09:34

OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, the stock’s daily moving averages and relative strength index (RSI) suggest caution for investors as price momentum shows signs of weakening.

Read full news article

When is the next results date for OneSource Specialty Pharma Ltd?

2026-05-08 23:17:32

The next results date for OneSource Specialty Pharma Ltd is scheduled for 13 May 2026....

Read full news article

OneSource Specialty Pharma Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-05-08 08:05:57

OneSource Specialty Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a strong day change of 4.24%, the stock’s technical indicators present a complex picture, with bullish signals on weekly MACD and Bollinger Bands contrasting with bearish RSI and mildly bearish daily moving averages. This nuanced technical landscape warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News